BPG is committed to discovery and dissemination of knowledge
Number of total visits
2735767
Number of visits today
605
Number of downloads
2006353
MEMBERSHIP
Cited by in F6Publishing
For:
Ren Y , Feng Y , Xu K , Yue S , Yang T , Nie K , Xu M , Xu H , Xiong X , Körte F , Barbeck M , Zhang P , Liu L . Enhanced Bioavailability of Dihydrotanshinone I-Bovine Serum Albumin Nanoparticles for Stroke Therapy. Front Pharmacol 2021;12 :721988. [PMID: 34531747 DOI: 10.3389/fphar.2021.721988 ] [ Cited by in Crossref: 3] [ Cited by in F6Publishing: 3 ] [ Article Influence: 1.5 ] [ Reference Citation Analysis ]
Number
Citing Articles
1
Wang M , Xiang Y , Wang R , Zhang L , Zhang H , Chen H , Luan X , Chen L . Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells. Molecules 2022;27 . [PMID: 36431875 DOI: 10.3390/molecules27227774 ] [ Reference Citation Analysis ]
2
Yue S , Zhang X , Xu Y , Zhu L , Cheng J , Qiao Y , Dai S , Zhu J , Jiang N , Wu H , Zhang P , Hou Y . The influence of surface charge on the tumor-targeting behavior of Fe3 O4 nanoparticles for MRI. J Mater Chem B 2022. [PMID: 34994759 DOI: 10.1039/d1tb02349g ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
3
Solanki R , Rostamabadi H , Patel S , Jafari SM . Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. Int J Biol Macromol 2021;193 :528-40. [PMID: 34655592 DOI: 10.1016/j.ijbiomac.2021.10.040 ] [ Cited by in Crossref: 16] [ Cited by in F6Publishing: 18 ] [ Article Influence: 8.0 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
